NDC 0032-2637 – Creon

Pancrelipase Lipase 36000 [USP'U]/1; Pancrelipase Amylase 180000 [USP'U]/1; Pancrelipase Protease 114000 [USP'U]/1 · Capsule, Delayed Release Pellets · Oral

Human Prescription Drug 2 recalls

Product NDC0032-2637

Product details

Brand name
Creon
Generic name
Pancrelipase
Labeler
AbbVie Inc.
Dosage form
Capsule, Delayed Release Pellets
Route
Oral
Marketing category
BLA · BLA020725
Marketed since
October 12, 2023
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Creon →

Package NDC codes (3)

Package NDCDescriptionSince
0032-2637-01100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2637-01)Oct 12, 2023
0032-2637-30 sample1 BOTTLE in 1 CARTON (0032-2637-30) / 24 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLEOct 12, 2023
0032-2637-70240 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2637-70)Oct 12, 2023

Recalls mentioning this NDC

Other Creon products